Ceftazidime, carbapenems, or piperacillin-tazobactam as single definitive therapy for Pseudomonas aeruginosa bloodstream infection - a multi-site retrospective study - Articles - Infectiology · Anesthesiology · Pain

SPECIAL REPORT

HIV / AIDS

11. Konferenz der Internationalen AIDS-Gesellschaft (IAS) 2021

Bacterial Infections

Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections: How Long is Long Enough?

Clin Infect Dis.

Fabre V, Amoah J, Cosgrove SE, Tamma PD

doi: 10.1093/cid/ciz223.

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

Lancet Infect Dis.

Gutiérrez-Gutiérrez B, Salamanca E, de Cueto M, Hsueh PR, Viale P, Paño-Pardo JR, Venditti M, Tumbarello M, Daikos G, Cantón R, Doi Y, Tuon FF, Karaiskos I, Pérez-Nadales E, Schwaber MJ, Azap ÖK, Souli M, Roilides E, Pournaras S, Akova M, Pérez F, Bermejo J, Oliver A, Almela M, Lowman W, Almirante B, Bonomo RA, Carmeli Y, Paterson DL, Pascual A, Rodríguez-Baño J; REIPI/ESGBIS/INCREMENT Investigators

doi: 10.1016/S1473-

Bacterial Infections

Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections

Clin Microbiol Infect.

Sánchez-Diener I, Zamorano L, Peña C, Ocampo-Sosa A, Cabot G, Gómez-Zorrilla S, Almirante B, Aguilar M, Granados A, Calbo E, Baño JR, Rodríguez-López F, Tubau F, Martínez-Martínez L, Navas A, Oliver A

doi: 10.1016/j.cmi.

Fungal Infections

Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study

Lancet Infect Dis.

Mejia-Chew C, O'Halloran JA, Olsen MA, Stwalley D, Kronen R, Lin C, Salazar AS, Larson L, Hsueh K, Powderly WG, Spec A

doi: 10.1016/S1473-3099(19)30405-0.

Drug Resistance

Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection

Clin Microbiol Infect.

Viasus D, Puerta-Alcalde P, Cardozo C, Suárez-Lledó M, Rodríguez-Núñez O, Morata L, Fehér C, Marco F, Chumbita M, Moreno-García E, Fernández-Avilés F, Gutiérrez-Garcia G, Martínez JA, Mensa J, Rovira M, Esteve J, Soriano A, Garcia-Vidal C, Hospital Clínic, Barcelona, Spain.

doi: 10.1016/j.cmi.

Bacterial Infections

Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections

doi: 10.1093/ofid/ofz505.

Bacterial InfectionsDrug Resistance

Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas Aeruginosa

Clin Infect Dis.

Pogue JM, Kaye KS, Veve MP, Patel TS, Gerlach AT, Davis SL, Puzniak LA, File TM, Olson S, Dhar S, Bonomo RA, Perez F

doi: 10.1093/cid/ciz816.

Bacterial InfectionsSepsis

Impact of baseline characteristics on future episodes of bloodstream infections: Multistate model in septic patients with bloodstream infections

Clin Infect Dis.

Vazquez Gusillamet MC, Vazquez R, Noe J, Micek ST, Fraser VJ, Kollef MH

doi: 10.1093/cid/ciz1206.

Related content

11. Konferenz der Internationalen AIDS-Gesellschaft (IAS) 2021

Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections: How Long is Long Enough?

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections

Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study

Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection

Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections

Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas Aeruginosa

Impact of baseline characteristics on future episodes of bloodstream infections: Multistate model in septic patients with bloodstream infections